OMX Nordic 40 2729754 / SE0001809476
2’437.72
Pkt
25.37
Pkt
1.05
%
17:35:08
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
| 20.12.24 | Novo Nordisk Neutral | UBS AG | |
| 20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.12.24 | ABB Neutral | UBS AG | |
| 18.12.24 | ABB Market-Perform | Bernstein Research | |
| 17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 17.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 16.12.24 | Novo Nordisk Neutral | UBS AG | |
| 16.12.24 | Volvo AB Buy | Deutsche Bank AG | |
| 16.12.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.12.24 | ABB Neutral | UBS AG | |
| 12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 10.12.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.12.24 | Novo Nordisk Neutral | UBS AG | |
| 09.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.12.24 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 09.12.24 | Nokia Overweight | JP Morgan Chase & Co. | |
| 06.12.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 05.12.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.12.24 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 04.12.24 | ABB Underweight | Barclays Capital | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.12.24 | Hennes & Mauritz AB Buy | UBS AG | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.11.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 27.11.24 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 26.11.24 | ABB Sector Perform | RBC Capital Markets | |
| 26.11.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 26.11.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 25.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 25.11.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
| 20.11.24 | Volvo AB Buy | Jefferies & Company Inc. |